PCN175 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MIDOSTAURIN FOR FLT3-POSITIVE ACUTE MYELOID LEUKEMIA (AML) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS).
Abstract
Authors
A. Buehler H.S.J. Kim L. Fahham A.L. Matsuo
A. Buehler H.S.J. Kim L. Fahham A.L. Matsuo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now